Bridgeway Capital Management’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
51,805
-23,500
-31% -$96.3K ﹤0.01% 1043
2026
Q1
$325K Buy
75,305
+30,000
+66% +$149K 0.01% 911
2025
Q4
$263K Hold
45,305
0.01% 967
2025
Q3
$174K Hold
45,305
﹤0.01% 1039
2025
Q2
$162K Hold
45,305
﹤0.01% 1003
2025
Q1
$115K Buy
+45,305
New +$168K ﹤0.01% 1011
2020
Q4
Sell
-14,000
Closed -$101K 1337
2020
Q3
$101K Hold
14,000
﹤0.01% 1257
2020
Q2
$126K Buy
+14,000
New +$142K ﹤0.01% 1216

Other funds holding KRMD

Bridgeway Capital Management's KRMD Position: Q2 2026 in Review

Bridgeway Capital Management reduced its KORU Medical Systems (KRMD) stake by 31% in Q2 2026, selling an estimated $96.3K and leaving 51,805 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1043.

Bridgeway Capital Management first reported a position in KRMD in Q2 2020 and has held it in 8 quarters since. The position peaked at $325K in Q1 2026. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Bridgeway Capital Management held 51,805 shares of KORU Medical Systems worth $218K as of Q2 2026.
  • Bridgeway Capital Management sold 23,500 KORU Medical Systems shares in Q2 2026, an estimated $96.3K.
  • KORU Medical Systems made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1043 holding.
  • Bridgeway Capital Management first reported a position in KORU Medical Systems in Q2 2020 and has held it in 8 quarters since.
  • Bridgeway Capital Management's KORU Medical Systems position peaked at $325K in Q1 2026.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.